0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Female Oral Contraceptives Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25H17572
Home | Market Reports | Health| Reproductive Health
Global Female Oral Contraceptives Market Research Report 2024
BUY CHAPTERS

Global Female Oral Contraceptives Market Research Report 2025

Code: QYRE-Auto-25H17572
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Female Oral Contraceptives Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Female Oral Contraceptives Market

Female Oral Contraceptives Market

The global market for Female Oral Contraceptives was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Female Oral Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Oral Contraceptives.
The Female Oral Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Female Oral Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Female Oral Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Female Oral Contraceptives Market Report

Report Metric Details
Report Name Female Oral Contraceptives Market
CAGR 5%
Segment by Type
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Janssen Global Services, Allergan,plc (Actavis), Teva Pharmaceutical, Piramal Enterprises, Pfizer, Merck, Mankind Pharma, Syzygy Healthcare, Ferring B.V
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Female Oral Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Female Oral Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Female Oral Contraceptives Market report?

Ans: The main players in the Female Oral Contraceptives Market are Bayer, Janssen Global Services, Allergan,plc (Actavis), Teva Pharmaceutical, Piramal Enterprises, Pfizer, Merck, Mankind Pharma, Syzygy Healthcare, Ferring B.V

What are the Application segmentation covered in the Female Oral Contraceptives Market report?

Ans: The Applications covered in the Female Oral Contraceptives Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Female Oral Contraceptives Market report?

Ans: The Types covered in the Female Oral Contraceptives Market report are Combination Pill, Progestin-only Pill, Continuous Use Pill

Recommended Reports

Women's Health

Oral Drug Markets

General Pharmaceutical

1 Female Oral Contraceptives Market Overview
1.1 Product Definition
1.2 Female Oral Contraceptives by Type
1.2.1 Global Female Oral Contraceptives Market Value Comparison by Type (2024 VS 2031)
1.2.2 Combination Pill
1.2.3 Progestin-only Pill
1.2.4 Continuous Use Pill
1.3 Female Oral Contraceptives by Application
1.3.1 Global Female Oral Contraceptives Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Female Oral Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Female Oral Contraceptives Revenue 2020-2031
1.4.2 Global Female Oral Contraceptives Sales 2020-2031
1.4.3 Global Female Oral Contraceptives Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Female Oral Contraceptives Market Competition by Manufacturers
2.1 Global Female Oral Contraceptives Sales Market Share by Manufacturers (2020-2025)
2.2 Global Female Oral Contraceptives Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Female Oral Contraceptives Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Female Oral Contraceptives, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Female Oral Contraceptives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Female Oral Contraceptives, Product Type & Application
2.7 Global Key Manufacturers of Female Oral Contraceptives, Date of Enter into This Industry
2.8 Global Female Oral Contraceptives Market Competitive Situation and Trends
2.8.1 Global Female Oral Contraceptives Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Female Oral Contraceptives Players Market Share by Revenue
2.8.3 Global Female Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Female Oral Contraceptives Market Scenario by Region
3.1 Global Female Oral Contraceptives Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Female Oral Contraceptives Sales by Region: 2020-2031
3.2.1 Global Female Oral Contraceptives Sales by Region: 2020-2025
3.2.2 Global Female Oral Contraceptives Sales by Region: 2026-2031
3.3 Global Female Oral Contraceptives Revenue by Region: 2020-2031
3.3.1 Global Female Oral Contraceptives Revenue by Region: 2020-2025
3.3.2 Global Female Oral Contraceptives Revenue by Region: 2026-2031
3.4 North America Female Oral Contraceptives Market Facts & Figures by Country
3.4.1 North America Female Oral Contraceptives Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Female Oral Contraceptives Sales by Country (2020-2031)
3.4.3 North America Female Oral Contraceptives Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Female Oral Contraceptives Market Facts & Figures by Country
3.5.1 Europe Female Oral Contraceptives Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Female Oral Contraceptives Sales by Country (2020-2031)
3.5.3 Europe Female Oral Contraceptives Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Female Oral Contraceptives Market Facts & Figures by Region
3.6.1 Asia Pacific Female Oral Contraceptives Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Female Oral Contraceptives Sales by Region (2020-2031)
3.6.3 Asia Pacific Female Oral Contraceptives Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Female Oral Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Female Oral Contraceptives Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Female Oral Contraceptives Sales by Country (2020-2031)
3.7.3 Latin America Female Oral Contraceptives Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Female Oral Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Female Oral Contraceptives Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Female Oral Contraceptives Sales by Country (2020-2031)
3.8.3 Middle East and Africa Female Oral Contraceptives Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Female Oral Contraceptives Sales by Type (2020-2031)
4.1.1 Global Female Oral Contraceptives Sales by Type (2020-2025)
4.1.2 Global Female Oral Contraceptives Sales by Type (2026-2031)
4.1.3 Global Female Oral Contraceptives Sales Market Share by Type (2020-2031)
4.2 Global Female Oral Contraceptives Revenue by Type (2020-2031)
4.2.1 Global Female Oral Contraceptives Revenue by Type (2020-2025)
4.2.2 Global Female Oral Contraceptives Revenue by Type (2026-2031)
4.2.3 Global Female Oral Contraceptives Revenue Market Share by Type (2020-2031)
4.3 Global Female Oral Contraceptives Price by Type (2020-2031)
5 Segment by Application
5.1 Global Female Oral Contraceptives Sales by Application (2020-2031)
5.1.1 Global Female Oral Contraceptives Sales by Application (2020-2025)
5.1.2 Global Female Oral Contraceptives Sales by Application (2026-2031)
5.1.3 Global Female Oral Contraceptives Sales Market Share by Application (2020-2031)
5.2 Global Female Oral Contraceptives Revenue by Application (2020-2031)
5.2.1 Global Female Oral Contraceptives Revenue by Application (2020-2025)
5.2.2 Global Female Oral Contraceptives Revenue by Application (2026-2031)
5.2.3 Global Female Oral Contraceptives Revenue Market Share by Application (2020-2031)
5.3 Global Female Oral Contraceptives Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Female Oral Contraceptives Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Janssen Global Services
6.2.1 Janssen Global Services Company Information
6.2.2 Janssen Global Services Description and Business Overview
6.2.3 Janssen Global Services Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Janssen Global Services Female Oral Contraceptives Product Portfolio
6.2.5 Janssen Global Services Recent Developments/Updates
6.3 Allergan,plc (Actavis)
6.3.1 Allergan,plc (Actavis) Company Information
6.3.2 Allergan,plc (Actavis) Description and Business Overview
6.3.3 Allergan,plc (Actavis) Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio
6.3.5 Allergan,plc (Actavis) Recent Developments/Updates
6.4 Teva Pharmaceutical
6.4.1 Teva Pharmaceutical Company Information
6.4.2 Teva Pharmaceutical Description and Business Overview
6.4.3 Teva Pharmaceutical Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pharmaceutical Female Oral Contraceptives Product Portfolio
6.4.5 Teva Pharmaceutical Recent Developments/Updates
6.5 Piramal Enterprises
6.5.1 Piramal Enterprises Company Information
6.5.2 Piramal Enterprises Description and Business Overview
6.5.3 Piramal Enterprises Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Piramal Enterprises Female Oral Contraceptives Product Portfolio
6.5.5 Piramal Enterprises Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Female Oral Contraceptives Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Female Oral Contraceptives Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Mankind Pharma
6.8.1 Mankind Pharma Company Information
6.8.2 Mankind Pharma Description and Business Overview
6.8.3 Mankind Pharma Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mankind Pharma Female Oral Contraceptives Product Portfolio
6.8.5 Mankind Pharma Recent Developments/Updates
6.9 Syzygy Healthcare
6.9.1 Syzygy Healthcare Company Information
6.9.2 Syzygy Healthcare Description and Business Overview
6.9.3 Syzygy Healthcare Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Syzygy Healthcare Female Oral Contraceptives Product Portfolio
6.9.5 Syzygy Healthcare Recent Developments/Updates
6.10 Ferring B.V
6.10.1 Ferring B.V Company Information
6.10.2 Ferring B.V Description and Business Overview
6.10.3 Ferring B.V Female Oral Contraceptives Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ferring B.V Female Oral Contraceptives Product Portfolio
6.10.5 Ferring B.V Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Female Oral Contraceptives Industry Chain Analysis
7.2 Female Oral Contraceptives Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Female Oral Contraceptives Production Mode & Process Analysis
7.4 Female Oral Contraceptives Sales and Marketing
7.4.1 Female Oral Contraceptives Sales Channels
7.4.2 Female Oral Contraceptives Distributors
7.5 Female Oral Contraceptives Customer Analysis
8 Female Oral Contraceptives Market Dynamics
8.1 Female Oral Contraceptives Industry Trends
8.2 Female Oral Contraceptives Market Drivers
8.3 Female Oral Contraceptives Market Challenges
8.4 Female Oral Contraceptives Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Female Oral Contraceptives Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Female Oral Contraceptives Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Female Oral Contraceptives Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Female Oral Contraceptives Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Female Oral Contraceptives Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Female Oral Contraceptives Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Female Oral Contraceptives Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Female Oral Contraceptives Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Female Oral Contraceptives, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Female Oral Contraceptives, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Female Oral Contraceptives, Product Type & Application
 Table 12. Global Key Manufacturers of Female Oral Contraceptives, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Female Oral Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Oral Contraceptives as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Female Oral Contraceptives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Female Oral Contraceptives Sales by Region (2020-2025) & (K Units)
 Table 18. Global Female Oral Contraceptives Sales Market Share by Region (2020-2025)
 Table 19. Global Female Oral Contraceptives Sales by Region (2026-2031) & (K Units)
 Table 20. Global Female Oral Contraceptives Sales Market Share by Region (2026-2031)
 Table 21. Global Female Oral Contraceptives Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Female Oral Contraceptives Revenue Market Share by Region (2020-2025)
 Table 23. Global Female Oral Contraceptives Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Female Oral Contraceptives Revenue Market Share by Region (2026-2031)
 Table 25. North America Female Oral Contraceptives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Female Oral Contraceptives Sales by Country (2020-2025) & (K Units)
 Table 27. North America Female Oral Contraceptives Sales by Country (2026-2031) & (K Units)
 Table 28. North America Female Oral Contraceptives Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Female Oral Contraceptives Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Female Oral Contraceptives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Female Oral Contraceptives Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Female Oral Contraceptives Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Female Oral Contraceptives Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Female Oral Contraceptives Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Female Oral Contraceptives Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Female Oral Contraceptives Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Female Oral Contraceptives Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Female Oral Contraceptives Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Female Oral Contraceptives Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Female Oral Contraceptives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Female Oral Contraceptives Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Female Oral Contraceptives Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Female Oral Contraceptives Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Female Oral Contraceptives Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Female Oral Contraceptives Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Female Oral Contraceptives Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Female Oral Contraceptives Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Female Oral Contraceptives Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Female Oral Contraceptives Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Female Oral Contraceptives Sales (K Units) by Type (2020-2025)
 Table 51. Global Female Oral Contraceptives Sales (K Units) by Type (2026-2031)
 Table 52. Global Female Oral Contraceptives Sales Market Share by Type (2020-2025)
 Table 53. Global Female Oral Contraceptives Sales Market Share by Type (2026-2031)
 Table 54. Global Female Oral Contraceptives Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Female Oral Contraceptives Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Female Oral Contraceptives Revenue Market Share by Type (2020-2025)
 Table 57. Global Female Oral Contraceptives Revenue Market Share by Type (2026-2031)
 Table 58. Global Female Oral Contraceptives Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Female Oral Contraceptives Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Female Oral Contraceptives Sales (K Units) by Application (2020-2025)
 Table 61. Global Female Oral Contraceptives Sales (K Units) by Application (2026-2031)
 Table 62. Global Female Oral Contraceptives Sales Market Share by Application (2020-2025)
 Table 63. Global Female Oral Contraceptives Sales Market Share by Application (2026-2031)
 Table 64. Global Female Oral Contraceptives Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Female Oral Contraceptives Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Female Oral Contraceptives Revenue Market Share by Application (2020-2025)
 Table 67. Global Female Oral Contraceptives Revenue Market Share by Application (2026-2031)
 Table 68. Global Female Oral Contraceptives Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Female Oral Contraceptives Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Female Oral Contraceptives Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Janssen Global Services Company Information
 Table 76. Janssen Global Services Description and Business Overview
 Table 77. Janssen Global Services Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Janssen Global Services Female Oral Contraceptives Product
 Table 79. Janssen Global Services Recent Developments/Updates
 Table 80. Allergan,plc (Actavis) Company Information
 Table 81. Allergan,plc (Actavis) Description and Business Overview
 Table 82. Allergan,plc (Actavis) Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Allergan,plc (Actavis) Female Oral Contraceptives Product
 Table 84. Allergan,plc (Actavis) Recent Developments/Updates
 Table 85. Teva Pharmaceutical Company Information
 Table 86. Teva Pharmaceutical Description and Business Overview
 Table 87. Teva Pharmaceutical Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Pharmaceutical Female Oral Contraceptives Product
 Table 89. Teva Pharmaceutical Recent Developments/Updates
 Table 90. Piramal Enterprises Company Information
 Table 91. Piramal Enterprises Description and Business Overview
 Table 92. Piramal Enterprises Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Piramal Enterprises Female Oral Contraceptives Product
 Table 94. Piramal Enterprises Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Female Oral Contraceptives Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck Female Oral Contraceptives Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Mankind Pharma Company Information
 Table 106. Mankind Pharma Description and Business Overview
 Table 107. Mankind Pharma Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mankind Pharma Female Oral Contraceptives Product
 Table 109. Mankind Pharma Recent Developments/Updates
 Table 110. Syzygy Healthcare Company Information
 Table 111. Syzygy Healthcare Description and Business Overview
 Table 112. Syzygy Healthcare Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Syzygy Healthcare Female Oral Contraceptives Product
 Table 114. Syzygy Healthcare Recent Developments/Updates
 Table 115. Ferring B.V Company Information
 Table 116. Ferring B.V Description and Business Overview
 Table 117. Ferring B.V Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ferring B.V Female Oral Contraceptives Product
 Table 119. Ferring B.V Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Female Oral Contraceptives Distributors List
 Table 123. Female Oral Contraceptives Customers List
 Table 124. Female Oral Contraceptives Market Trends
 Table 125. Female Oral Contraceptives Market Drivers
 Table 126. Female Oral Contraceptives Market Challenges
 Table 127. Female Oral Contraceptives Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Female Oral Contraceptives
 Figure 2. Global Female Oral Contraceptives Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Female Oral Contraceptives Market Share by Type: 2024 & 2031
 Figure 4. Combination Pill Product Picture
 Figure 5. Progestin-only Pill Product Picture
 Figure 6. Continuous Use Pill Product Picture
 Figure 7. Global Female Oral Contraceptives Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Female Oral Contraceptives Market Share by Application: 2024 & 2031
 Figure 9. Online Sales
 Figure 10. Offline Sales
 Figure 11. Global Female Oral Contraceptives Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Female Oral Contraceptives Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Female Oral Contraceptives Sales (2020-2031) & (K Units)
 Figure 14. Global Female Oral Contraceptives Average Price (US$/Unit) & (2020-2031)
 Figure 15. Female Oral Contraceptives Report Years Considered
 Figure 16. Female Oral Contraceptives Sales Share by Manufacturers in 2024
 Figure 17. Global Female Oral Contraceptives Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Female Oral Contraceptives Players: Market Share by Revenue in Female Oral Contraceptives in 2024
 Figure 19. Female Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Female Oral Contraceptives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Female Oral Contraceptives Sales Market Share by Country (2020-2031)
 Figure 22. North America Female Oral Contraceptives Revenue Market Share by Country (2020-2031)
 Figure 23. United States Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Female Oral Contraceptives Sales Market Share by Country (2020-2031)
 Figure 26. Europe Female Oral Contraceptives Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Female Oral Contraceptives Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Female Oral Contraceptives Revenue Market Share by Region (2020-2031)
 Figure 34. China Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Female Oral Contraceptives Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Female Oral Contraceptives Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Female Oral Contraceptives Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Female Oral Contraceptives Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Female Oral Contraceptives Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Female Oral Contraceptives by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Female Oral Contraceptives by Type (2020-2031)
 Figure 53. Global Female Oral Contraceptives Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Female Oral Contraceptives by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Female Oral Contraceptives by Application (2020-2031)
 Figure 56. Global Female Oral Contraceptives Price (US$/Unit) by Application (2020-2031)
 Figure 57. Female Oral Contraceptives Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Tadalafil Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12D16691
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ganirelix Acetate Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7B16887
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Single Use Uterine Manipulator Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15L16691
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Assisted Reproductive Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10C16781
Thu Sep 25 00:00:00 UTC 2025

Add to Cart